LAURA WILLSHER: Open Payments
NPI 1306809777 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,615 in 52 payments from 23 companies in 2025. Trend: 2023 $1,405 · 2024 $2,096 · 2025 $2,615
Food & beverage: $2,615
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $329 |
| Axsome Therapeutics, Inc. | 4 | $280 |
| Insulet Corporation | 3 | $260 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $186 |
| ABBVIE INC. | 9 | $160 |
| Amgen Inc. | 5 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $140 |
| Neurocrine BioSciences, Inc. | 1 | $129 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Abbott Laboratories | 1 | $121 |
Products named: Auvelity, OMNIPOD, Ozempic, JARDIANCE, VRAYLAR, CAPLYTA, Wegovy, BREZTRI.
Industry payments across LA — which companies pay providers there.
